NEW

Stryker Launches New Tendon Fixation Device System

Stryker’s Trauma & Extremities division has launched its Citrelock Tendon Fixation Device System. The new system provides surgeons a differentiated design via a tendon thread featuring a resorbable technology, known as Citregen, that has unique chemical and...

ACS Advocacy Efforts for Suicide Awareness Underway

Through its Surgeon Well-Being program, the American College of Surgeons (ACS) is working to build awareness about suicide during September, which is National Suicide Awareness and Prevention Month. During September, ACS is releasing several communications for its...

Intermountain Healthcare Postpones Non-Urgent Surgeries and Procedures

Intermountain Healthcare is postponing all non-urgent surgeries and procedures requiring a hospital admission in its trauma and community hospitals, starting September 15, to support ICUs and acute care units and staffing needs.

Encompass Group LLC Awarded Contract with Vizient

Encompass Group LLC has been awarded a contract with Vizient to supply health care apparel uniforms to Vizient members. Effective August 15, 2021, Vizient members can order Encompass Healthcare Apparel directly from Encompass or through their authorized distributor,...

Study: Surfacide UV-C Light Effective in Pediatric Burn Hospital

A recent study at Shriners Hospitals for Children-Cincinnati, one of only four freestanding hospitals in the country dedicated to the treatment of pediatric burns and specializing in plastic and reconstructive surgery, concluded that the Surfacide Helios UV-C Disinfection System is “… an effective and integral component in reducing bacterial pathogens not killed by the EVS (manual) cleaning process alone.”

The findings were published at the American Burn Association’s 49th Annual Meeting in Boston earlier this year. The authors discussed their findings from 234 cultures obtained from rooms and noted a 37 percent organism reduction from terminal cleaning alone. When the Surfacide UV-C Disinfection System was used in addition to the EVS terminal cleaning process, the authors reported a “total elimination of pathogens.”

“Surfacide’s Helios system incorporates three UV-C energy emitting towers in the patient environment to eradicate drug-resistant organisms, including superbugs such as C. Diff, MRSA, VRE, CRE and Acinetobacter,” said Gunner Lyslo, founder and CEO of Surfacide LLC. “The system has been shown in studies to significantly reduce the risk of HAIs and lower hospital infection rates.”

The 10- to 20-minute Surfacide disinfection cycle is performed in an unoccupied room, after an environmental services cleaning professional has manually cleaned the area and wiped down surfaces. Treating the room with UV-C energy is an evidence-based disinfection modality disinfecting areas that were not completely cleaned manually.

Other systems use a single tower. Surfacide’s multiple emitter approach disinfects an entire room in just one cycle, including the bathroom and other hard-to-reach areas more quickly and effectively. The Helios emitters are positioned closer to hard surfaces, thereby reducing UV-C disinfection time and improving overall efficacy.

Health care providers are turning to UV-C technology as a complement to traditional cleaning methods to combat healthcare-associated infections (HAIs). UV-C energy (at 254nm) is the peak germ-killing part of the ultraviolet spectrum.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X